Want to join the conversation?
Pharmacy benefit manager $ESRX reported a jump in 2Q16 earnings driven by lower costs and expenses despite a slight decline in revenues. Net income rose to $720.7MM or $1.13 per share from $600.1MM or $0.88 per share last year. Revenues slid to $25.22Bil from $25.45Bil. Adjusted EPS grew to $1.57 from $1.44.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)